Effects of fulvestrant 250 mg in premenopausal women with oestrogen receptor-positive primary breast cancer

被引：0

作者：

Robertson, J. F. R.

Semiglazov, V.

Nemsadze, G.

Dzagnidze, G.

Janjalia, M.

Nicholson, R. I.

Gee, J. M. W.

Armstrong, J.

机构：

[1] City Hosp Nottingham, Nottingham, England

[2] NN Petrov Oncol Res Inst, St Petersburg, Russia

[3] Natl Oncol Ctr, Georgian Canc Study Grp, Tbilisi, Georgia

[4] Tenovus Ctr Canc Res, Cardiff, Wales

[5] AstraZeneca, Macclesfield, Cheshire, England

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：587 / 588

页数：2